DATATRAK International, Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Alex Tabatabai
- Full Time Employees
- 13
- Sector
- Technology
- Industry
- Software - Application
- Address
- 5900 Landerbrook Drive Mayfield Heights OH United States of America 44124
- IPO Date
- Jun 11, 1996
- Website
- fountayn.com
- Similar Companies
- Business
- DATATRAK International, Inc. (DTRK) provides unified eClinical solutions and related services for the clinical trials industry, including cloud-based software platforms such as DATATRAK ONE Unified Experience featuring UX CTMS 360 for trial planning and management; UX Trial for design-to-deployment; UX EDC and Medical Coding for data capture and delivery; UX Randomization and Trial Supply Management for patient randomization and supply automation; UX Patient Data Capture; UX Safety; UX Training for user training and certification tracking; eTMF for document management; and eConsent/ePRO for decentralized patient access and informed consent; along with DATATRAK Clinical Consulting Services encompassing training, support, SaaS hosting, standards development, and trial design. The company, founded in 1991 and headquartered in Mayfield Heights, Ohio, operates globally in over 83 countries, serving contract research organizations, pharmaceutical and biotech firms, academic research organizations, and medical device companies with FDA 21 CFR Part 11, HIPAA, GDPR, and GCP compliant technology. In early 2022, DATATRAK underwent a significant rebranding to Fountayn, introducing a modernized platform interface, enhanced training modules, updated help documentation, and new leadership under CEO Alex Tabatabai to align with its advanced eClinical offerings while maintaining core functionality in EDC, CTMS, and RTSM.
DATATRAK Standalone eConsent Accelerates Clinical Trials
Vuzix (NASDAQ:VUZI) vs. Datatrak International (OTCMKTS:DTRK) Financial Survey
CRO Selects Datatrak eSource for $1,800,000 Contract
CRO Selects Datatrak eTMF & ePRO for $6,600,000 Contract
Global CRO Switches to Datatrak eTMF for All its Clinical Trial Documentation and Processes
European CRO Commits to Datatrak eClinical Technology Platform for All-In-One Clinical Trial Data Solutions for eSource, EDC, RTSM, eTMF, CTMS, eConsent, and ePRO
eClinical Solutions Market and Companies Analysis Report 2025: Features Key Players Anju Software, BioClinicia, Parexel International Corporation, CRF Health, and Datatrak International
Datatrak International, Inc. Discusses Potential of Its eClinicial and Predictive Analytics Platforms with The Stock Day Podcast
Datatrak International, Inc. Reports Results for Second Quarter and First Half of 2021
Datatrak International, Inc. Reports First Quarter Results for 2021
Datatrak International Launches ePRO, eCOA and eConsent Solution to Support the Advancement of Decentralized Trials Globally